Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Cash & Equivalents: 2020-2024

Historic Cash & Equivalents for iSpecimen (ISPC) over the last 5 years, with Dec 2024 value amounting to $1.9 million.

  • iSpecimen's Cash & Equivalents rose 58.85% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year increase of 58.85%. This contributed to the annual value of $1.9 million for FY2024, which is 19.85% down from last year.
  • According to the latest figures from FY2024, iSpecimen's Cash & Equivalents is $1.9 million, which was down 19.85% from $2.3 million recorded in FY2023.
  • iSpecimen's Cash & Equivalents' 5-year high stood at $27.7 million during FY2021, with a 5-year trough of $695,909 in FY2020.
  • Moreover, its 3-year median value for Cash & Equivalents was $2.3 million (2023), whereas its average is $6.5 million.
  • Per our database at Business Quant, iSpecimen's Cash & Equivalents surged by 3,886.01% in 2021 and then tumbled by 84.69% in 2023.
  • Over the past 5 years, iSpecimen's Cash & Equivalents (Yearly) stood at $695,909 in 2020, then skyrocketed by 3,886.01% to $27.7 million in 2021, then tumbled by 44.81% to $15.3 million in 2022, then crashed by 84.69% to $2.3 million in 2023, then fell by 19.85% to $1.9 million in 2024.